A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes

NCT05297045 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to financial constraint.

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: RGT001-075
OTHER: Placebo

Sponsor

Regor Pharmaceuticals Inc.